Federated Hermes’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $221K | Sell |
|
|||||
|
2025
Q2 | $323K | Sell |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $2.64M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.32K | Sell |
|
|||||
|
2022
Q4 | $4.25K | Sell |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $7K | Buy |
|
|||||
|
2021
Q4 | $6K | Buy |
|
|||||
|
2021
Q3 | $7K | Buy |
|